This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
An overview of widely used market indices, with examples and brief explanations of their constituents, aims, and how investors leverage them.
27,821 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
May data show 7.6 million job openings, topping forecasts and signaling stabilization in the labor market. Thursday's...
Micron unveils a $200 billion expansion to meet AI memory demand, and the company says even customers couldn’t foreca...
A new study links AI spending to increased hiring in large U.S. firms, suggesting productivity gains precede payroll ...
BonkDAO reports a $20 million loss following a governance attack that exploited a proposal flaw. Upbit has paused BON...
Alphabet and Taiwan Semiconductor posted powerful Q1 2026 results, illustrating two distinct routes to AI profit: in-...
June brought a notable rally for Bank of America shares. This article breaks down the key drivers behind bank america...
Investors are increasingly favoring dividend growth over high yields, signaling a shift toward smaller dividends that...
TrueDAO has closed a $10 million strategic funding round led by Brevan Howard Digital, with Zee Prime Capital and Jum...
The Trump Accounts program promises big future wealth for kids, but financial experts caution that projected outcomes...
Johnson & Johnson and Coca-Cola posted strong Q1 2026 results as markets rotate toward defensive plays. The big quest...
A 72-year-old returns to work after medical bills and rising living costs erode his Social Security, highlighting ris...